These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 25488519)

  • 1. Production methods for viral particles.
    Machida K; Imataka H
    Biotechnol Lett; 2015 Apr; 37(4):753-60. PubMed ID: 25488519
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The application of virus-like particles as vaccines and biological vehicles.
    Yan D; Wei YQ; Guo HC; Sun SQ
    Appl Microbiol Biotechnol; 2015 Dec; 99(24):10415-32. PubMed ID: 26454868
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suitability and perspectives on using recombinant insect cells for the production of virus-like particles.
    Yamaji H
    Appl Microbiol Biotechnol; 2014 Mar; 98(5):1963-70. PubMed ID: 24407451
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Insect cells as a production platform of complex virus-like particles.
    Fernandes F; Teixeira AP; Carinhas N; Carrondo MJ; Alves PM
    Expert Rev Vaccines; 2013 Feb; 12(2):225-36. PubMed ID: 23414412
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Production and applications of engineered viral capsids.
    Glasgow J; Tullman-Ercek D
    Appl Microbiol Biotechnol; 2014 Jul; 98(13):5847-58. PubMed ID: 24816622
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression and self-assembly of virus-like particles of infectious hypodermal and hematopoietic necrosis virus in Escherichia coli.
    Hou L; Wu H; Xu L; Yang F
    Arch Virol; 2009; 154(4):547-53. PubMed ID: 19252812
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Production and characterization of virus-like particles and the P domain protein of GII.4 norovirus.
    Koho T; Huhti L; Blazevic V; Nurminen K; Butcher SJ; Laurinmäki P; Kalkkinen N; Rönnholm G; Vesikari T; Hytönen VP; Kulomaa MS
    J Virol Methods; 2012 Jan; 179(1):1-7. PubMed ID: 21600929
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Engineered retroviral virus-like particles for receptor targeting.
    Voráčková I; Ulbrich P; Diehl WE; Ruml T
    Arch Virol; 2014 Apr; 159(4):677-88. PubMed ID: 24132720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Purification of norovirus-like particles (VLPs) by ion exchange chromatography.
    Koho T; Mäntylä T; Laurinmäki P; Huhti L; Butcher SJ; Vesikari T; Kulomaa MS; Hytönen VP
    J Virol Methods; 2012 Apr; 181(1):6-11. PubMed ID: 22265819
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The N-terminal region containing the zinc finger domain of tobacco streak virus coat protein is essential for the formation of virus-like particles.
    Mathur C; Mohan K; Usha Rani TR; Krishna Reddy M; Savithri HS
    Arch Virol; 2014 Mar; 159(3):413-23. PubMed ID: 24036956
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Production of Brazilian human norovirus VLPs and comparison of purification methods.
    Lamounier TA; de Oliveira LM; de Camargo BR; Rodrigues KB; Noronha EF; Ribeiro BM; Nagata T
    Braz J Microbiol; 2015; 46(4):1265-8. PubMed ID: 26691489
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Self-assembly of the recombinant capsid protein of a swine norovirus into virus-like particles and evaluation of monoclonal antibodies cross-reactive with a human strain from genogroup II.
    Almanza H; Cubillos C; Angulo I; Mateos F; Castón JR; van der Poel WH; Vinje J; Bárcena J; Mena I
    J Clin Microbiol; 2008 Dec; 46(12):3971-9. PubMed ID: 18842943
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of polymorphism displayed by the coat protein mutants of tomato bushy stunt virus.
    Hsu C; Singh P; Ochoa W; Manayani DJ; Manchester M; Schneemann A; Reddy VS
    Virology; 2006 May; 349(1):222-9. PubMed ID: 16603216
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Engineering Virus-like Particles for Antigen and Drug Delivery.
    Hill BD; Zak A; Khera E; Wen F
    Curr Protein Pept Sci; 2018; 19(1):112-127. PubMed ID: 27875963
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced assembly and colloidal stabilization of primate erythroparvovirus 1 virus-like particles for improved surface engineering.
    Sánchez-Rodríguez SP; Morán-García Adel C; Bolonduro O; Dordick JS; Bustos-Jaimes I
    Acta Biomater; 2016 Apr; 35():206-14. PubMed ID: 26911883
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human parvovirus B19 virus-like particles: In vitro assembly and stability.
    Sánchez-Rodríguez SP; Münch-Anguiano L; Echeverría O; Vázquez-Nin G; Mora-Pale M; Dordick JS; Bustos-Jaimes I
    Biochimie; 2012 Mar; 94(3):870-8. PubMed ID: 22192916
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Purification and visualization of encephalomyocarditisvirus synthesized by an in vitro protein expression system derived from mammalian cell extract.
    Kobayashi T; Yukigai J; Ueda K; Machida K; Masutani M; Nishino Y; Miyazawa A; Imataka H
    Biotechnol Lett; 2013 Mar; 35(3):309-14. PubMed ID: 23143176
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Purification and concentration of non-infectious West Nile virus-like particles and infectious virions using a pseudo-affinity Cellufine Sulfate column.
    Ohtaki N; Takahashi H; Kaneko K; Gomi Y; Ishikawa T; Higashi Y; Todokoro M; Kurata T; Sata T; Kojima A
    J Virol Methods; 2011 Jun; 174(1-2):131-5. PubMed ID: 21440004
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Efficient disulfide bond formation in virus-like particles.
    Bundy BC; Swartz JR
    J Biotechnol; 2011 Jul; 154(4):230-9. PubMed ID: 21536082
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biochemical and physical characterization of parvovirus minute virus of mice virus-like particles.
    Hernando E; Llamas-Saiz AL; Foces-Foces C; McKenna R; Portman I; Agbandje-McKenna M; Almendral JM
    Virology; 2000 Feb; 267(2):299-309. PubMed ID: 10662625
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.